dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:23:40Z
dc.date.accessioned2022-10-05T18:13:32Z
dc.date.available2014-05-27T11:23:40Z
dc.date.available2022-10-05T18:13:32Z
dc.date.created2014-05-27T11:23:40Z
dc.date.issued2008-10-01
dc.identifierEcletica Quimica, v. 33, n. 4, p. 7-12, 2008.
dc.identifier0100-4670
dc.identifierhttp://hdl.handle.net/11449/70596
dc.identifier10.1590/S0100-46702008000400001
dc.identifierS0100-46702008000400001
dc.identifier2-s2.0-58649119855
dc.identifier2-s2.0-58649119855.pdf
dc.identifier5978908591853524
dc.identifier3192125098361121
dc.identifier0000-0003-0197-7369
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3919876
dc.description.abstractA simple analytical method for quantification of atenolol in pharmaceutical formulations by diffuse reflectance spectroscopy is described. The method is based on the reaction, on the filter paper surface, between the drug and p-chloranil producing a colored compound. The best reaction conditions were obtained with 20 μL of atenolol solution and 20 μL of p-chloranil. All reflectance measurements were carried out at 550 nm and the linear range was from 1.13×10-2 to 7.88×10-2 mol L-1 (r = 0.9992). The limit of detection was 2.80 × 10-3 mol L-1. The proposed method was successfully applied to analysis of different commercial brands of pharmaceutical formulations and the results obtained by the proposed method were in good agreement with those obtained using the British Pharmacopoeia method.
dc.languageeng
dc.relationEclética Química
dc.relation25798
dc.relation32204
dc.relation25326
dc.relation68510
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAtenolol
dc.subjectDiffuse reflectance spectroscopy
dc.subjectp-chloranil, pharmaceutical formulations
dc.titleDetermination of atenolol in pharmaceutical formulations by diffuse reflectance spectroscopy
dc.typeArtigo


Este ítem pertenece a la siguiente institución